Vitek2AST-N335药敏卡检测鲍曼不动杆菌头孢哌酮/舒巴坦药物敏感性的方法学评价
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

南通市市级科技计划(社MSZ2024052,MSZ2023120)


Performance evaluation of Vitek 2 AST-N335 card for testing susceptibility of Acinetobacter baumannii to cefoperazone/sul-bactam
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的评估Vitek2AST-N335药敏卡检测鲍曼不动杆菌(AB)对头孢哌酮/舒巴坦药物敏感性结果的可靠性。方法收集2023年临床分离318株非重复AB,采用微量肉汤稀释法(BMD)、AST-N335药敏卡和K-B纸片扩散法对头孢哌酮/舒巴坦进行抗菌药物敏感性试验。以BMD为参考方法,评估AST-N335卡的可靠性,验证K-B纸片扩散法作为复核方法的准确性。结果与BMD相比,318株AB对头孢哌酮/舒巴坦的药敏检测显示,AST-N335卡分类一致率(CA)为 87.8%(279/318)、非常重大误差(VME)为6.0%(19/318)、重大误差(ME)为0%(0/318)、小误差(mE)为1.9%(6/318),为不可接受误差范围;K-B纸片扩散法CA为99.4%(316/318)、VME为0%、ME为0.3%(1/318)、mE为0.3%(1/318),为可接受误差范围。其中AST-N335卡误差均发生在最低抑菌浓度(MIC)8~32μg/mL之间。进一步对171株AST-N335卡头孢哌酮/舒巴坦MIC结果为 8~32μg/mL的AB进行分析,以 BMD为参考方法,MIC为32μg/mL时,CA为O%;MIC为16μg/mL时,CA为5.3%(1/19)、VME为84.2%(16/19),均严重偏离可接受误差范围;MIC为8μg/mL时,CA为94.9%(131/138),VME为2.2%(3/138),接近可接受范围。结论Vitek2AST-N335卡检测AB头孢哌酮/舒巴坦MIC值在8~32μg/mL的AB时结果不可靠,降低了头孢哌酮/舒巴坦的耐药率,需引起实验室和临床高度重视,K-B纸片扩散法可作为实验室日常检测的复核方法。

    Abstract:

    Abstract: ObjectiveTo evaluate the reliability of Vitek 2 AST-N335 card for determining the susceptibility of Acinetobacter bauman-nii(AB) to cefoperazone/sulbactam. MethodsA total of 318 non-repeated clinical isolates of AB collected in 2023were tested for antimicrobial susceptibility to cefoperazone/sulbactam using broth microdilution(BMD),the AST-N335 card, and the Kirby-Bauer (K-B) disk diffusion method. Using BMD as the reference method, the reliability of AST-N335 card was assessed, and the accuracy of K-B disk diffusion method as the confirmatory test was validated. ResultsCompared with BMD,the susceptibility testing of 318 AB strains to cefoperazone/sulbactam using the AST-N335 card showed categorical agrement(CA) of 87.8% (279/318),very major error(VME)of 6.0%(19/318),major error(ME)of 0%(O/318),and minor error(mE)of 1.9%(6/318),which fall outside of the acceptable error range. In contrast,the K-B method achieved CA of 99.4%(316/318),VME of 0%,ME of 0.3%(1/318),and mE of O.3% (1/318),all within acceptable limits.Of these,the errors with AST-N335 card occurred within the minimum inhibitory concentration (MIC) range of 8-32 pg/mL. Using BMD as the reference method, further analysis was performed on the 171 AB strains with AST-N335 card MIC values of 8-32 pg/mL for cefoperazone/sulbactam. It was revealed that at MIC of 32pg/mL,the CA was 0%;at MIC of 16 pg/mL,CA was5.3% (1/19)and VME rate was 84.2% (16/19),both of which substantially exceeded acceptable error ranges. At MIC of 8 pg/mL,the CA was 94.9% (131/138)and VME was 2.2% (3/138),both approaching the acceptable ranges. ConclusionThe results obtained with Vitek 2 AST-N335 card in determining for cefoperazone/sulbactam are unreliable when the MIC values fall within the range of 8-32pg/mL,which leads to an underestimation of the resistance rate to cefoperazone/sulbac-tam.This issue requiresurgent attention inboth laboratoriesand clinical practice.The K-B diskdiffusion method could serve asasup- plementary verification approach in routine laboratories.

    参考文献
    相似文献
    引证文献
引用本文

顾玲莉,沈红梅,黄琳玲,许美蓉,刘海萍,刘培龙,刘香,戴世荣. Vitek2AST-N335药敏卡检测鲍曼不动杆菌头孢哌酮/舒巴坦药物敏感性的方法学评价[J].临床检验杂志,2025,43(10):794-797

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-02-08
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-11-26
  • 出版日期:
文章二维码
您是第位访问者  苏ICP备13058113号-3
苏公网安备32010202012004号
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司